These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2144593)

  • 1. Hepatitis B carriers in a centre for the mentally retarded in Finland and immunogenicity of hepatitis B vaccine.
    Mölsä PK
    J Ment Defic Res; 1990 Aug; 34 ( Pt 4)():379-83. PubMed ID: 2144593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor seroconversion rate after hepatitis B vaccination in high-risk institutionalized mentally retarded patients.
    Cooper BW; Klimek JJ; Upadhyaya A; Devine S
    Am J Infect Control; 1986 Oct; 14(5):204-8. PubMed ID: 3641542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term observation of the effect of intradermal hepatitis B vaccination on mentally retarded patients.
    Hayashi J; Noguchi A; Nakashima K; Morofuji M; Kashiwagi S
    Eur J Epidemiol; 1991 Nov; 7(6):649-53. PubMed ID: 1838338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B vaccination in Down's syndrome and other mentally retarded patients.
    Heijtink RA; De Jong P; Schalm SW; Masurel N
    Hepatology; 1984; 4(4):611-4. PubMed ID: 6235163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of immunity to hepatitis B vaccination in institutionalized mentally retarded patients.
    Torre D; Broggini M; Botta V; Sampietro C
    Vaccine; 1989 Apr; 7(2):102-3. PubMed ID: 2526418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deinstitutionalized mentally retarded hepatitis-B surface antigen carriers in public school classes: a descriptive study.
    Bakal CW; Marr JS; Novick LF; Millner ES; Goldman WD; Pitkin OE
    Am J Public Health; 1980 Jul; 70(7):709-11. PubMed ID: 7386705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B screening and immunization for people with a mental handicap in Southampton: costs and benefits.
    Arulrajan AE; Tyrie CM; Phillips K; O'Connell S
    J Intellect Disabil Res; 1992 Jun; 36 ( Pt 3)():259-64. PubMed ID: 1535820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developments in immunization against hepatitis B.
    Zuckerman AJ
    Ann Ist Super Sanita; 1987; 24(2):285-91. PubMed ID: 2969206
    [No Abstract]   [Full Text] [Related]  

  • 10. The control of hepatitis B virus infection with vaccine in Japanese nursery schools.
    Hayashi J; Kashiwagi S; Nomura H; Kajiyama W; Ikematsu H
    Am J Epidemiol; 1987 Sep; 126(3):474-9. PubMed ID: 2956878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Seroconversion following immunization with a plasma-derived vaccine against hepatitis B: study of a 3-injection protocol (0, 1, 6 months) in Brazzaville (Congo)].
    Taty-Taty R; Saliou P; Yala F; Couroucé AM; Arthaud ML; Nerelli B; Biendo M; Wassoumbou E
    Bull Soc Pathol Exot; 1990; 83(2):155-8. PubMed ID: 2145083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B vaccination of relatives of hepatitis B virus DNA positive carriers: an experience with plasma-derived vaccine.
    Craxì A; Vinci M; Almasio P; Pagliaro L
    Eur J Epidemiol; 1989 Mar; 5(1):65-9. PubMed ID: 2523316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers.
    Lee CY; Huang LM; Chang MH; Hsu CY; Wu SJ; Sung JL; Safary A
    Pediatr Infect Dis J; 1991 Apr; 10(4):299-303. PubMed ID: 1829515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma in young, mentally retarded HBsAg carriers without cirrhosis.
    Lohiya G; Pirkle H; Hoefs J; Lohiya S; Ngo VT
    Hepatology; 1985; 5(5):824-6. PubMed ID: 2993146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B vaccination for staff in institutions for the mentally handicapped.
    Jayaratnam R
    Public Health; 1988 May; 102(3):257-62. PubMed ID: 2968611
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men.
    Hadler SC; Francis DP; Maynard JE; Thompson SE; Judson FN; Echenberg DF; Ostrow DG; O'Malley PM; Penley KA; Altman NL
    N Engl J Med; 1986 Jul; 315(4):209-14. PubMed ID: 2941687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of a recombinant DNA hepatitis B vaccine in institutionalized patients with Down's syndrome.
    Van Damme P; Vranckx R; Meheus A
    Vaccine; 1990 Mar; 8 Suppl():S53-5; discussion S60-2. PubMed ID: 2139285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers.
    Poovorawan Y; Sanpavat S; Pongpunlert W; Chumdermpadetsuk S; Sentrakul P; Safary A
    JAMA; 1989 Jun; 261(22):3278-81. PubMed ID: 2523981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Active preventive vaccination against hepatitis B].
    Jilg W
    Internist (Berl); 1985 Oct; 26(10):633-9. PubMed ID: 2934346
    [No Abstract]   [Full Text] [Related]  

  • 20. Status of hepatitis B screening and vaccine use in facilities for mentally retarded persons.
    Dandoy S; Dandoy JR
    Am J Ment Defic; 1986 Sep; 91(2):184-9. PubMed ID: 2945434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.